Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
37972
CAS Number:
123663-49-0
Iguratimod
Purity:
≥ 98 % (HPLC)
Synonym(s):
N- (3-Formamido-4-oxo-6-fenoxi- 4H- cromen-7-il)metanosulfonamida, N- [7-(Metanesulfonamido)-4-oxo-6-fenoxi- 4H- cromen-3-il]formamida
Documents
$61.19 /25 mg
Tamaño
Request Bulk Quote
Información del producto

Conservar bajo gas inerte.

Número CAS
123663-49-0
Fórmula molecular
C17H14N2O6S
Peso molecular
374.37
Número MDL
MFCD00882374
Punto de fusión
238 - 242 °C
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
123663-49-0
Fórmula molecular
C17H14N2O6S
Peso molecular
374.37
Número MDL
MFCD00882374
Punto de fusión
238 - 242 °C
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Iguratimod is widely utilized in research focused on:

  • Rheumatoid Arthritis Treatment: This compound is primarily used as a disease-modifying antirheumatic drug (DMARD) to manage rheumatoid arthritis, helping to reduce inflammation and joint damage.
  • Immunomodulation: Iguratimod has applications in modulating the immune response, making it valuable in autoimmune disease research and therapies.
  • Pharmaceutical Development: It serves as a lead compound in the development of new anti-inflammatory medications, providing a basis for creating more effective treatments with fewer side effects.
  • Research on Chronic Inflammation: The compound is studied for its effects on chronic inflammatory conditions, offering insights into potential therapies for diseases like lupus and psoriasis.
  • Combination Therapies: Iguratimod is explored in combination with other drugs to enhance therapeutic efficacy, particularly in complex cases of autoimmune disorders.

Citas